Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Exclusion Criteria

• •Women who are pregnant or lactating.
• •Received another investigational drug or device within 30 days.
• •Recent parenteral or oral iron therapy.
• •Patients with active GI bleeding or acute bleeding within 4 weeks.
• •Patients that have other causes of anemia.
• •Major surgery within 30 days or anticipated or planned major surgery during the study.
• •Patients whose EPO status changes while on study.
• •Patients with active infections.
• •Recent blood transfusions.
• •Patients with any known allergies to iron products.